IM Cannabis reports Q2 results
IMCC Stock | USD 3.99 0.30 8.13% |
About 64% of all Im Cannabis' shareholders are looking to take a long position. The analysis of the overall investor sentiment regarding Im Cannabis Corp suggests that some traders are interested. The current market sentiment, together with Im Cannabis' historical and current headlines, can help investors time the market. In addition, many technical investors use Im Cannabis Corp stock news signals to limit their universe of possible portfolio assets.
IMCC |
IM Cannabis reports second-quarter financial results with GAAP EPS of -C0.23 and revenue of C14.8M, up 12.1 percent year-over-year.
Read at seekingalpha.com
Im Cannabis Investor Sentiment by Other News Outlets
Investor sentiment, mood or attitude towards Im Cannabis can have a significant impact on its stock price or the market as a whole. This sentiment can be positive or negative, and various factors, such as economic indicators, news events, or market trends, can influence it. When investor sentiment is positive, investors are more likely to buy stocks, increasing demand and increasing the stock price. Positive investor sentiment can be driven by good news about the company or the broader market, such as solid earnings reports or positive economic data.
Note that negative investor sentiment can cause investors to sell stocks, leading to a decrease in demand and a drop in the stock price. Negative sentiment can be driven by factors such as poor earnings reports, negative news about the company or industry, or broader economic concerns. It's important to note that investor sentiment is just one of many factors that can affect stock prices. Other factors, such as company performance, industry trends, and global economic conditions, can also play a significant role in determining the value of a stock.
Im Cannabis Fundamental Analysis
We analyze Im Cannabis' financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Im Cannabis using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Im Cannabis based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Shares Owned By Insiders
Shares Owned By Insiders Comparative Analysis
Im Cannabis is currently under evaluation in shares owned by insiders category among its peers. Shares Owned by Insiders show the percentage of outstanding shares owned by insiders (such as principal officers or members of the board of directors) or private individuals and entities with over 5% of the total shares outstanding. Company executives or private individuals with access to insider information share information about a firm's operations that is not available to the general public.
Im Cannabis Corp Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Im Cannabis stock to make a market-neutral strategy. Peer analysis of Im Cannabis could also be used in its relative valuation, which is a method of valuing Im Cannabis by comparing valuation metrics with similar companies.
Peers
Im Cannabis Related Equities
CLVR | Clever Leaves | 999,900 | ||||
RAPH | Raphael Pharmaceutical | 13.04 | ||||
UPC | Universe Pharmaceuticals | 3.49 | ||||
PAHC | Phibro Animal | 0.93 | ||||
SUPN | Supernus Pharmaceuticals | 1.14 | ||||
IXHL | Incannex Healthcare | 2.20 | ||||
AAWH | Ascend Wellness | 2.44 | ||||
BFRI | Biofrontera | 9.09 |
Complementary Tools for IMCC Stock analysis
When running Im Cannabis' price analysis, check to measure Im Cannabis' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Im Cannabis is operating at the current time. Most of Im Cannabis' value examination focuses on studying past and present price action to predict the probability of Im Cannabis' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Im Cannabis' price. Additionally, you may evaluate how the addition of Im Cannabis to your portfolios can decrease your overall portfolio volatility.
Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
Money Managers Screen money managers from public funds and ETFs managed around the world | |
Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk | |
Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
Price Ceiling Movement Calculate and plot Price Ceiling Movement for different equity instruments |